Clinical Trial Results:
IMMUNOGENICITY OF A COMMERCIAL BATCH OF THE JAPANESE ENCEPHALITIS VACCINE IC51 UP TO TWENTY-FOUR MONTHS POST FILLING, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY
Summary
|
|
EudraCT number |
2008-004634-24 |
Trial protocol |
DE AT |
Global completion date |
30 Jun 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Feb 2016
|
First version publication date |
27 Feb 2016
|
Other versions |
|
Summary report(s) |
IC51-314_Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.